Dedifferentiated Chondrosarcoma
4 clinical trials · Condition
◉ Watch Dedifferentiated Chondrosarcoma
| Record | Firm | Date |
|---|---|---|
| Testing Atezolizumab in People 2-17 Years Old With Clear Cell Sarcoma or Advanced Chondrosarcoma (NCT04458922) | National Cancer Institute (NCI) | 2020-10-05 |
| LN-145 or LN-145-S1 in Treating Patients With Relapsed or Refractory Ovarian Cancer, Triple Negative Breast Cancer (TNBC), Anaplastic Thyroid Cancer, Osteosarcoma, or Other Bone and Soft Tissue Sarcomas (NCT03449108) | M.D. Anderson Cancer Center | 2018-04-27 |
| Sirolimus and Cyclophosphamide in Metastatic or Unresectable Myxoid Liposarcoma and Chondrosarcoma (NCT02821507) | Leiden University Medical Center | 2014-06-01 |
| Vismodegib in Treating Patients With Advanced Chondrosarcomas (NCT01267955) | National Cancer Institute (NCI) | 2010-12-21 |
Track Dedifferentiated Chondrosarcoma automatically
Every clearance here is in the API, with alerts when new ones post.